Fifth Eye, Inc., a provider of intuitive real-time clinical analytics, today announced that it has been recognized as a “Top Ten Artificial Intelligence Solutions Provider” for the second consecutive year. The designation by Healthcare Tech Outlook spotlights Fifth Eye’s AHI System™ as a unique, real-time medical software solution that enables clinicians to detect and predict hemodynamic instability that can point to serious adverse events hours or even days ahead of vital signs1.

Healthcare Tech Outlook is a print and digital platform that serves those involved with selecting and implementing healthcare technology. Each year, they publish a Top Ten list that “assists healthcare organizations in finding the foremost solution providers that can help them effectively navigate the ever-evolving artificial intelligence space.” 

With the help of data science, Fifth Eye discovered a way to get ahead of traditional vital signs by monitoring Heart Rate Variability (HRV) and ECG morphology features. HRV is the part of the autonomic nervous system that measures the variation in time between heartbeats. HRV is a predictor of hemodynamic risk – variations in blood flow – that can signal decompensation, the acute decline in clinical status that poses a substantial risk of shock leading to a crisis event.

Fifth Eye CEO Andrew Malcolmson said, “We are thrilled to have been once again recognized for the AI innovation that powers AHI System. Hospitals are challenged daily to provide appropriate levels of care while under significant financial and resource constraints. AHI is making a real difference in the lives of clinicians and patients, and we are pleased to have that acknowledged once again.”

AHI is the only FDA-cleared clinical decision support device of its kind, giving care teams the time to plan and intervene to avoid a costly crash crisis, improve patient throughput with informed care-level downgrades, and support better allocation of clinical staff resources to avoid nursing burnout.

AHI System software is intended for use by healthcare professionals managing in-hospital patients 18 years or older who are receiving continuous physiological monitoring with ECG. AHI surveillance may be initiated on patients monitored with bedside, telemetry or wearable patch ECG and standard electrodes.


About Fifth Eye Inc.

Fifth Eye, Inc. is an Ann Arbor, Michigan-based company that develops intuitive, real-time clinical analytics based on physiologic waveforms to improve outcomes and reduce costs. The AHI System™ is the first and only FDA cleared clinical decision support software that continuously predicts the risk of hemodynamic instability earlier than vital signs. AI-powered AHI extracts information embedded in a Lead II ECG signal alone – no manual or other inputs required. Fifth Eye’s machine-learning technology is licensed from the University of Michigan. For more information, please visit


1Internal study